Clinical Study Evaluating Turmeric for Rheumatoid Arthritis (RA) Treatment

Clinical study evaluating Turmeric for Rheumatoid Arthritis (RA) treatment. Looking for individuals with poorly controlled RA currently not on a biologic medication.

For more information contact us at botanicals@email.arizona.edu or 694-4744

Study phase: I

Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.

  • Active RA

  • Currently not taking a biologic medication

Additional information:

The purpose of this study is to find out whether turmeric dietary supplements that are available over the counter for general use in the United States are safe and useful when taken specifically for the treatment of rheumatoid arthritis (RA) and how the active principles in turmeric are broken down and metabolized by the body in individuals with RA.

Primary disease category: Arthritis

Sponsor: National Institutes of Health

Projected enrollment dates: February 2016 to September 2017

Official study title: Phase Ib Randomized, Double-BIind, Placebo-Controlled Study of Meriva in Rheumatoid Arthritis (Curcuma longa L in Rheumatoid Arthritis [CLaRA] Phase I) or CLaRA